European Society of Toxicology In Vitro > Uncategorized > in3 Project – virtual meeting on December 14 and 15, 2020
12 December 2020

in3 Project – virtual meeting on December 14 and 15, 2020

The in3 project will held its final meeting on December 14 and 15, 2020.

– The first day – December 14 – will be dedicated to Carrer development
– The second day – December 15 – will discuss the results of the IN3 Project
The Programm and the speakers are available at https://estiv.org/in3/index.php

About the in3 Project

The in3 project is funded by the EU’s Marie Sklodowska-Curie Action – Innovative Training Network (MSCA-ITN for short) that aims to drive the synergistic development and utilisation of in vitro and in silico tools for human chemical and nanomaterial (NM) safety assessment.

Coordinator: Prof. Dr. Paul Jennings p.jennings@vu.nl
Training coordinator: Dr.Maxime Culot  maxime.culot@univ-artois.fr
Project manager: Dr. Ellen Langemeijer e.v.langemeijer@vu.nl

Related content

The new Biomedical research report from ECVAM: Tackling neurodegenerative diseases with more human relevant research

To promote more human relevant research, the JRC’s EU Reference Laboratory for alternatives to animal testing (EURL ECVAM) led a study to review advanced non-animal models used in the field of neurodegenerative diseases, specifically for Parkinson’s and Alzheimer’s.

ESTIV Corporate member’s event: EPISKIN ACADEMY Webinar

The second EPISKIN webinar is focusing on the theme eye irritation and Integrated Approaches to Testing and Assessment (IATA) for Serious Eye Damage and Eye Irritation for regulatory toxicology…

Corporate Members

mattek in Vitro Life Science Laboratories

Affiliated Societies

Invitrom Celltox IVTS

Memorandum of Understanding